Abstract
Molecular testing is now part of the standard of care pathway for many types of solid tumours with new tests being required to be introduced into laboratories quite rapidly. As part of the quality process external quality assessment (EQA) is required to ensure that the results obtained in this testing are accurate.
This talk will provide an overview of how EQAs for molecular pathology are delivered, summarise the results for some of these EQAs highlighting some of the issues observed. It will also highlight some of the different technologies used for testing and how reporting of results is assessed in the EQAs
Learning outcomes
Delegates will learn and understand:
- How GenQA organises EQA schemes
- Which different methods are used by laboratories for testing
- The pitfalls in testing and reporting
×
Dr Jennie Fairely
Deputy Director GenQA (Mol Path), GenQA
Jenni is one of the Deputy Directors of GenQA (Genomics Quality Assessment) where she has been responsible for delivering EQA for molecular pathology of solid tumours for nearly 10 years. GenQA is part of the UK National External Quality Assessment Service (UK NEQAS) and delivers assessment of the full clinical genomics testing pathway through more than a hundred different EQAs.
Jenni is a registered clinical scientist in molecular pathology and was a postdoctoral researcher working in the cancer field before taking up her training in the NHS.